Corporate News     14-Mar-24
Board of Eris Lifesciences approves acquisition of branded formulations biz of Biocon Biologics
Also approved acquisition of 19% stake in Swiss Parenterals
The Board of Eris Lifesciences at its meeting held on 14 March 2024 has approved the following:

➢ Agreement to acquire the Branded Formulations businesses of Biocon Biologics pertaining to the Indian Territory to the extent and in the manner mentioned therein.

➢ Agreement to acquire 19% equity stake in Swiss Parenterals from the Promoters of the Company.

Previous News
  ERIS Lifesciences consolidated net profit rises 0.86% in the December 2023 quarter
 ( Results - Announcements 14-Feb-24   14:33 )
  ERIS Lifesciences allots 14,717 equity shares under ESOP
 ( Corporate News - 21-Jun-22   19:51 )
  ERIS Lifesciences consolidated net profit rises 17.66% in the March 2022 quarter
 ( Results - Announcements 03-May-22   15:49 )
  Lemon Tree Hotels Ltd leads losers in 'A' group
 ( Hot Pursuit - 17-Nov-21   15:00 )
  ERIS Lifesciences consolidated net profit rises 17.96% in the June 2019 quarter
 ( Results - Announcements 29-Jul-19   10:10 )
  ERIS Lifesciences acquires Zomelis' and its associated trademarks from Novartis AG
 ( Corporate News - 04-Dec-19   09:41 )
  Dr. Reddy's Laboratories sells non-core dermatology brands
 ( Corporate News - 17-Mar-23   13:48 )
  ERIS Lifesciences consolidated net profit rises 3.64% in the March 2020 quarter
 ( Results - Announcements 02-Jun-20   13:33 )
  ERIS Lifesciences announces board meeting date
 ( Corporate News - 30-Jul-22   12:12 )
  DRL inks pact with Eris Life to divest certain non-brands
 ( Hot Pursuit - 17-Mar-23   10:23 )
  ERIS Lifesciences allots 5,032 equity shares under ESOP
 ( Corporate News - 22-Dec-23   16:03 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top